Hover to zoom

Growth Hormone ResearchSynthetic GHRH analog (trans-3-hexenoyl modified)

Tesamorelin

$69.99

10 mg· 2 strengths available

Tesamorelin is a synthetic analog of growth-hormone-releasing hormone (GHRH) carrying a trans-3-hexenoyl group that slows enzymatic degradation.

In laboratory research it is used as a stable GHRH receptor agonist for studying pituitary somatotroph signaling and the pulsatile regulation of the growth-hormone axis in preclinical models.

Research areas

GHRH receptor signalingSomatotroph pathway researchEndocrine axis studiesPreclinical research

Form: Lyophilized (freeze-dried)

Compound class: Synthetic GHRH analog (trans-3-hexenoyl modified)
Research category: Growth Hormone Research
SKU: NVR-TESAMORELIN-10MG
Alternate name: Tesa
Appearance: White lyophilized powder
Storage: Store lyophilized at −20 °C. Protect from light and moisture.

Research use only

Select strength

Cost per mg shown for each option

$69.99per 10 mg$7.00/mg

For research use only — not for human or animal consumption.

Supplied solely for legitimate laboratory and research purposes. Not for medical or veterinary use, diagnosis, treatment, or prevention of disease.

Research Grade

Batch Documentation

Research Use Only

U.S.-Based Fulfillment

What you should know

More detail on Tesamorelin.

Analytical values reflect per-lot documentation and appear once a batch is released.

Compound

Native GHRH is cleaved rapidly by dipeptidyl peptidase-4, which complicates experiments that require sustained receptor engagement. The acyl modification in tesamorelin addresses that limitation, making it a practical reagent for time-course work at the GHRH receptor. Research applications include characterizing receptor-mediated cyclic-AMP responses in pituitary-derived cell lines, comparing GHRH-analog potency, and modeling how the hypothalamic–pituitary axis responds to sustained versus pulsatile stimulation. All applications are experimental and research-use only.

Peptide class

Synthetic GHRH analog (trans-3-hexenoyl modified)

Mechanism (research context)

Tesamorelin engages the GHRH receptor with extended stability compared to native GHRH, and is used as a defined GHRH-analog reference peptide in the receptor-pharmacology literature.

Why it is studied

Tesamorelin is one of the well-characterized long-acting GHRH analogs, cited in comparative somatotropic-axis pharmacology.

Current areas of research

GHRH receptor signalingSomatotroph pathway researchEndocrine axis studiesPreclinical research

Topics reflect published preclinical and in vitro research. Reference only — not a claim of clinical outcomes.

Scientific background

Tesamorelin was developed as a GHRH-analog with an acyl modification improving stability against enzymatic degradation.

It has been the subject of extensive published receptor-pharmacology work.

Batch number

Batch documentation will be added when inventory is released.

Purity

Batch documentation will be added when inventory is released.

Analytical method

RP-HPLC & mass spectrometry (per lot documentation)

Testing laboratory

Independent third-party analytical laboratory

Batch documentation will be added when inventory is released. Once a batch is released, its analytical records and Certificate of Analysis are linked here. Requests: grant@novarynresearch.com.

Research Grade

Batch Documentation Where Available

Laboratory Handling Guidance

Laboratory Use Only

Laboratory concentration calculator

Use the selected research-material amount and your chosen total liquid volume to calculate laboratory concentration.

Material amount

10 mgSelected

From the selected Tesamorelin strength.

Total liquid volume

Mathematical laboratory concentration calculation only. This tool does not provide preparation recommendations of any kind.

Calculations are a laboratory reference for in vitro work only. No preparation, administration, or human-use guidance is provided.

Storage

Store lyophilized at −20 °C. Protect from light and moisture.

Form

Lyophilized (freeze-dried) powder

Shipping conditions

Ships from the United States in packaging appropriate to the product's storage requirements. Cold-chain packaging is used where required.

Handling recommendations

Handle per institutional laboratory protocols. Wear appropriate PPE, minimize exposure to light and moisture, and record lot information on the working aliquot.

Product name

Tesamorelin

Peptide class

Synthetic GHRH analog (trans-3-hexenoyl modified)

Research category

Growth Hormone Research

Available sizes

10 mg — $69.99 20 mg — $119.99

Appearance

White lyophilized powder

Delivery form

Lyophilized (freeze-dried) powder

CAS number

Batch documentation will be added when inventory is released.

Molecular formula

Batch documentation will be added when inventory is released.

Molecular weight

Batch documentation will be added when inventory is released.

Purity specification

≥ 98% (per lot documentation, when available)

Solubility

Batch documentation will be added when inventory is released.

Storage temperature

Store lyophilized at −20 °C. Protect from light and moisture.

Shelf life

24 months lyophilized under recommended storage

Laboratory use

For in vitro research use only. Not for human or veterinary use.

Alternate names

Tesa · TH9507

Subscribe & Save

Every 30 days · 10% off · Every 60 days · 15% off · Every 90 days · 20% off

Tesamorelin incorporates an N-terminal acyl modification that extends its research-model stability relative to sermorelin.

Lyophilized materials are typically reconstituted with bacteriostatic water. Follow institutional protocols and consult the applicable batch documentation when available.

Materials ship in insulated packaging appropriate to their handling requirements. Cold-chain packaging is used where required by the product's storage guidance.

Batch-specific documentation, including a Certificate of Analysis, is provided when available for the released lot. Contact grant@novarynresearch.com for outstanding requests.